Oncorus, Inc.

Oncorus, Inc. is an early-stage biotechnology company developing a next-generation immunotherapy platform of oncolytic viruses to treat several types of cancer, including highly malignant and aggressive cancers. The platform is based on a next generation of oncolytic herpesvirus (oHSV) platform for tumor lysis and immuno-oncology.